NEWARK, Del., Aug. 13 -- Almost 18 months have passed since investigators with the COURAGE trial reported the stunning news that for patients with stable angina, stenting offered no survival benefit over optimal medical therapy.
In this exclusive 乌鸦传媒 video report, we present highlights of the original controversy surrounding this trial, including comments from representatives of the American College of Cardiology, the American Heart Association, and the Society for Cardiovascular Angiography and Interventions.